Blood eosinophil count (BEC) measured before starting inhaled corticosteroids (ICS) is better associated with treatment response to ICS in COPD.

被引：0
|
作者：
Mathioudakis, Alexander [1 ]
Bate, Sebastian [2 ]
Sivapalan, Pradeesh [3 ]
Jensen, Jens-Ulrik [3 ]
Singh, Dave
Vestbo, Jorgen [1 ]
机构：
[1] Univ Manchester, Sch Biol Sci, Div Immunol Immun Infect & Resp Med, Manchester, Lancs, England
[2] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Res & Innovat, Manchester, Lancs, England
[3] Copenhagen Univ Hosp, Sect Resp Med, Dept Med, Herlev & Gentofte, Copenhagen, Denmark
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.OA2608
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 24 条
  • [11] Blood eosinophil count in patients with COPD on inhaled corticosteroids in comparison with healthy smoker and nonsmoker controls
    Ahmed, Noha Othman
    Daif, Marwa Sayed
    Ghani, Amani Mohamed Abdel
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2021, 70 (02): : 188 - 194
  • [12] The influence of Adherence to inhaled Corticosteroids (ICS) on treatment Response to mepolizumab treatment in severe Eosinophilic asthma
    Almutairi, Mohammed
    Marriott, John
    Jalal, Zahraa
    Wood, Louise
    Almoosawi, Batool
    Caddick, Samantha
    Rajkumari, Babita
    Renwick, Susan
    Wilkinson, Siobhan
    Gallagher, Caroline
    Duffin, Thomas
    Mansur, Adel
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [13] Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept
    Leuppi, JD
    Tandjung, R
    Anderson, SD
    Stolz, D
    Brutsche, MH
    Bingisser, R
    Perruchoud, AP
    Surber, C
    Knoblauch, A
    Andersson, M
    Greiff, L
    Chan, HK
    Tamm, M
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2005, 18 (02) : 83 - 88
  • [14] Study of blood eosinophils and plasma periostin as biomarkers for response of COPD patients to ICS/LABA treatment
    Abdulsattar, Sara Abdulbadie
    Hantera, Mohamed Sayed
    Hodeb, Hossam Abdel Mohsen
    Kholy, Amira Abdelgalil El
    Kholy, Gamal Amer El
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2024, 18 (01)
  • [15] Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS
    Latorre, M.
    Novelli, F.
    Vagaggini, B.
    Braido, F.
    Papi, A.
    Sanduzzi, A.
    Santus, P.
    Scichilone, N.
    Paggiaro, P.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 30 : 44 - 50
  • [16] Effects of inhaled corticosteroids (ICS) on lung microbiota and local immune response in long-term treatment of chronic obstructive pulmonary disease (COPD): utility of titration and therapeutic index
    Toraldo, Domenico Maurizio
    Rizzo, Emanuele
    Conte, Luana
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (07) : 849 - 858
  • [17] Effects of inhaled corticosteroids (ICS) on lung microbiota and local immune response in long-term treatment of chronic obstructive pulmonary disease (COPD): utility of titration and therapeutic index
    Domenico Maurizio Toraldo
    Emanuele Rizzo
    Luana Conte
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, 395 : 849 - 858
  • [18] Air trapping measured at HRCT predicts benralizumab response better than blood eosinophil count in severe asthma
    Bourdin, Arnaud
    Beclin, Marie Felicia
    Chanez, Pascal
    Vachier, Isabelle
    Pahus, Laurie
    Nogue, Erika
    Pissarra, Joana
    Bommart, Sebastien
    Molinari, Nicolas
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [19] Patient-Reported Clinical Control and Peak-Flow: Effects of 30 Versus 6 Month Treatment with Inhaled Corticosteroids (ICS) with/without Long-Acting β2-Agonists (LABA) in Moderately Severe COPD.
    Snoeck-Stroband, J. B.
    Lapperre, T. S.
    Gosman, M. M. E.
    Assendelft, W. J. J.
    Boezen, H. M.
    ten Hacken, N. H. T.
    van der Molen, T.
    Hiemstra, P. S.
    Postma, D. S.
    Sterk, P. J.
    Sont, J. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [20] LATE-BREAKING ABSTRACT: Blood eosinophils (EOS) are a biomarker of COPD exacerbation reduction with inhaled corticosteroids (ICS): An across-trials model- based approach
    Siddiqui, Salman H.
    Pavord, Ian
    Barnes, Neil C.
    Lettis, Sally
    Guasconi, Alessandro
    Petruzzelli, Stefano
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
123